Your browser doesn't support javascript.
loading
Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program.
Stewart, A; Roberts, J A; Wallis, S C; Allworth, A M; Legg, A; McCarthy, K L.
Afiliação
  • Stewart A; Infectious Diseases Unit, Royal Brisbane and Women's Hospital, Queensland, Australia. Electronic address: adm_stewart@hotmail.com.
  • Roberts JA; Department of Pharmacy, Royal Brisbane and Women's Hospital, Queensland, Australia; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
  • Wallis SC; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
  • Allworth AM; Infectious Diseases Unit, Royal Brisbane and Women's Hospital, Queensland, Australia.
  • Legg A; Department of Pharmacy, Royal Brisbane and Women's Hospital, Queensland, Australia.
  • McCarthy KL; Infectious Diseases Unit, Royal Brisbane and Women's Hospital, Queensland, Australia; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Int J Antimicrob Agents ; 51(6): 941-942, 2018 06.
Article em En | MEDLINE | ID: mdl-29471023

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Pseudomonas / Cefalosporinas / Tazobactam / Abscesso Pulmonar / Antibacterianos Limite: Humans / Male / Middle aged Idioma: En Revista: Int J Antimicrob Agents Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Pseudomonas / Cefalosporinas / Tazobactam / Abscesso Pulmonar / Antibacterianos Limite: Humans / Male / Middle aged Idioma: En Revista: Int J Antimicrob Agents Ano de publicação: 2018 Tipo de documento: Article
...